Search research articles
Contact Us
Filters
Showing results (71-80 of 111) with videos related to
Page
of 12
Sort By:
Environmental Research
|
March 1, 2021
Assessing the potential of unmanned aerial vehicle spraying of aqueous ozone as an outdoor disinfectant for SARS-CoV-2
Simon Albert, Alberto A Amarilla, Ben Trollope, et al.
Vaccines
|
March 6, 2020
Bovine Herpesvirus-4-Vectored Delivery of Nipah Virus Glycoproteins Enhances T Cell Immunogenicity in Pigs
Miriam Pedrera, Francesca Macchi, Rebecca K McLean, et al.
Nature Communications
|
November 5, 2025
Author Correction: A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicity
Summa Bibby, James Jung, Yu Shang Low, et al.
Frontiers in Nuclear Medicine
|
October 2, 2024
Development and evaluation of an <sup>18</sup>F-labeled nanobody to target SARS-CoV-2's spike protein
Sara Lopes van den Broek, Rocío García-Vázquez, Ida Vang Andersen, et al.
Virology
|
January 17, 2016
Discovery and characterisation of a new insect-specific bunyavirus from Culex mosquitoes captured in northern Australia
Jody Hobson-Peters, David Warrilow, Breeanna J McLean, et al.
Virology
|
November 1, 2015
A novel insect-specific flavivirus replicates only in Aedes-derived cells and persists at high prevalence in wild Aedes vigilax populations in Sydney, Australia
Breeanna J McLean, Jody Hobson-Peters, Cameron E Webb, et al.
Viruses
|
September 25, 2020
A Unique Relative of Rotifer Birnavirus Isolated from Australian Mosquitoes
Caitlin A O'Brien, Cassandra L Pegg, Amanda S Nouwens, et al.
NPJ Vaccines
|
November 9, 2021
Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
Christopher L D McMillan, Stacey T M Cheung, Naphak Modhiran, et al.
NPJ Vaccines
|
January 6, 2022
Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
Christopher L D McMillan, Stacey T M Cheung, Naphak Modhiran, et al.
Plos Pathogens
|
July 17, 2025
A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus
Andrew Young, Sharada Kolekar, Carlos Alvarez Mendoza, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 111) with videos related to
Sort By:
Page
of 12
Environmental Research
|
March 1, 2021
Assessing the potential of unmanned aerial vehicle spraying of aqueous ozone as an outdoor disinfectant for SARS-CoV-2
Simon Albert, Alberto A Amarilla, Ben Trollope, et al.
Vaccines
|
March 6, 2020
Bovine Herpesvirus-4-Vectored Delivery of Nipah Virus Glycoproteins Enhances T Cell Immunogenicity in Pigs
Miriam Pedrera, Francesca Macchi, Rebecca K McLean, et al.
Nature Communications
|
November 5, 2025
Author Correction: A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicity
Summa Bibby, James Jung, Yu Shang Low, et al.
Frontiers in Nuclear Medicine
|
October 2, 2024
Development and evaluation of an <sup>18</sup>F-labeled nanobody to target SARS-CoV-2's spike protein
Sara Lopes van den Broek, Rocío García-Vázquez, Ida Vang Andersen, et al.
Virology
|
January 17, 2016
Discovery and characterisation of a new insect-specific bunyavirus from Culex mosquitoes captured in northern Australia
Jody Hobson-Peters, David Warrilow, Breeanna J McLean, et al.
Virology
|
November 1, 2015
A novel insect-specific flavivirus replicates only in Aedes-derived cells and persists at high prevalence in wild Aedes vigilax populations in Sydney, Australia
Breeanna J McLean, Jody Hobson-Peters, Cameron E Webb, et al.
Viruses
|
September 25, 2020
A Unique Relative of Rotifer Birnavirus Isolated from Australian Mosquitoes
Caitlin A O'Brien, Cassandra L Pegg, Amanda S Nouwens, et al.
NPJ Vaccines
|
November 9, 2021
Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
Christopher L D McMillan, Stacey T M Cheung, Naphak Modhiran, et al.
NPJ Vaccines
|
January 6, 2022
Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
Christopher L D McMillan, Stacey T M Cheung, Naphak Modhiran, et al.
Plos Pathogens
|
July 17, 2025
A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus
Andrew Young, Sharada Kolekar, Carlos Alvarez Mendoza, et al.
Page
of 12